RadioMedix
TX - HoustonPharmaceutical
Focus: RadioMedix is a specialized radiopharmaceutical company focused on imaging and therapeutic agents for oncology and nephrology, operating as a public company headquartered in Houston with 20+ years of innovation in nuclear medicine.
Profile data last refreshed 10h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
1
Should You Work at RadioMedix?
AI assessmentRadioMedix offers deep technical specialization in a high-potential niche but limited hiring scale and financial opacity present execution risk for career growth.
Why Work Here
- Exclusive focus on high-growth radiopharmaceutical space with FDA approval momentum (Ga-68 PSMA-11 approved June 2026) and expanding pipeline across oncology and nephrology.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Post-LOE
ANDA-approved generic radiopharmaceutical enabling PSMA-targeted PET imaging in prostate cancer; represents company's established market presence.
Products & Portfolio (1)
Help build intelligence for RadioMedix
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.